Development and Optimization of Multifunctional Smart Nanocarriers for Stimuli Responsive and Site-Specific Delivery of Anticancer Agents
Keywords:
Smart Nanocarriers, Stimuli-Responsive, Anticancer Agents, Targeted Drug Delivery, Biocompatibility, Tumor TargetingAbstract
The development of multifunctional smart nanocarriers has revolutionized the field of targeted drug delivery, particularly for anticancer agents. These nanocarriers are designed to respond to specific stimuli, such as pH, temperature, or enzymatic activity, enabling site-specific delivery and minimizing off-target effects. This research focuses on the optimization of nanocarrier systems to enhance their therapeutic efficacy, biocompatibility, and stability. By integrating advanced materials and surface functionalization techniques, we demonstrate the potential of these nanocarriers to improve drug release kinetics and tumor targeting. Experimental data and computational modeling were employed to validate the performance of the optimized systems. The findings highlight the promise of smart nanocarriers in overcoming the limitations of conventional chemotherapy and improving patient outcomes.
References
[1] Zhang, Y., et al. (2020). pH-sensitive liposomes for targeted delivery of doxorubicin. Journal of Controlled Release, 320, 1-12.
[2] Wang, X., et al. (2021). Redox-responsive polymeric nanoparticles for cancer therapy. Biomaterials, 270, 120678.
[3] Li, J., et al. (2019). Magnetic nanoparticles for hyperthermia-induced drug release. *Nanomedicine, 14(5), 567-580.
[4] Chen, L., et al. (2022). Hybrid nanocarriers for improved drug delivery. Advanced Drug Delivery Reviews, 180, 114057.
[5] Gupta, A., et al. (2018). PEGylation of nanocarriers for enhanced circulation time. *International Journal of Pharmaceutics, 548(1), 1-10.
[6] Lee, S., et al. (2020). Biodegradable polymers in drug delivery. Progress in Polymer Science, 102, 101208.
[7] Patel, S., et al. (2021). "Stimuli-responsive nanocarriers for targeted cancer therapy: A review of recent advancements." Advanced Healthcare Materials, 10(15), 2100023.
[8] Kumar, R., et al. (2020). "pH-responsive polymeric nanoparticles for tumor-targeted drug delivery: Synthesis, characterization, and in vitro evaluation." International Journal of Nanomedicine, 15, 9119–9133.
[9] Gao, W., et al. (2019). "Redox-responsive nanocarriers for intracellular drug delivery: Mechanisms and applications." Bioconjugate Chemistry, 30(4), 1017–1030.
[10] Liu, Y., et al. (2022). "Magnetic nanoparticles for cancer therapy: Recent progress and challenges." Nano Today, 42, 101358.
[11] Shi, J., et al. (2020). "Enzyme-responsive nanocarriers for targeted drug delivery in cancer therapy." Journal of Materials Chemistry B, 8(35), 7871–7885.
[12] Alavi, M., et al. (2021). "Hybrid nanocarriers for combination therapy in cancer treatment: Challenges and opportunities." Drug Discovery Today, 26(4), 1006–1018.
